These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24286997)

  • 1. Contraceptive procedures.
    Beasley A; Schutt-Ainé A
    Obstet Gynecol Clin North Am; 2013 Dec; 40(4):697-729. PubMed ID: 24286997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting reversible contraception: a review in special populations.
    Prescott GM; Matthews CM
    Pharmacotherapy; 2014 Jan; 34(1):46-59. PubMed ID: 24130075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of unintended pregnancy: a focus on long-acting reversible contraception.
    Pickle S; Wu J; Burbank-Schmitt E
    Prim Care; 2014 Jun; 41(2):239-60. PubMed ID: 24830607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraceptive methods available to patients of office-based physicians and title X clinics --- United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jan; 60(1):1-4. PubMed ID: 21228760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the uptake of long acting reversible contraception: a review.
    Michie L; Cameron ST
    Minerva Ginecol; 2013 Jun; 65(3):241-52. PubMed ID: 23689167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-savings from the provision of specific contraceptive methods in 2009.
    Foster DG; Biggs MA; Malvin J; Bradsberry M; Darney P; Brindis CD
    Womens Health Issues; 2013; 23(4):e265-71. PubMed ID: 23816157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends and determinants of use of long-acting reversible contraception use among young women in France: results from three national surveys conducted between 2000 and 2010.
    Moreau C; Bohet A; Hassoun D; Teboul M; Bajos N;
    Fertil Steril; 2013 Aug; 100(2):451-8. PubMed ID: 23663994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meeting the contraceptive needs of teens and young adults: youth-friendly and long-acting reversible contraceptive services in U.S. family planning facilities.
    Kavanaugh ML; Jerman J; Ethier K; Moskosky S
    J Adolesc Health; 2013 Mar; 52(3):284-92. PubMed ID: 23298980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting reversible contraceptives: intrauterine devices and the contraceptive implant.
    Espey E; Ogburn T
    Obstet Gynecol; 2011 Mar; 117(3):705-719. PubMed ID: 21343774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductions in pregnancy rates in the USA with long-acting reversible contraception: a cluster randomised trial.
    Harper CC; Rocca CH; Thompson KM; Morfesis J; Goodman S; Darney PD; Westhoff CL; Speidel JJ
    Lancet; 2015 Aug; 386(9993):562-8. PubMed ID: 26091743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices.
    Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2012 Oct; 120(4):983-8. PubMed ID: 22996129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Acting Reversible Contraceptives and Adolescents: Assessing Benefits and Overcoming Barriers.
    McKnight ER; Berlan ED
    Adolesc Med State Art Rev; 2014 Aug; 25(2):347-59. PubMed ID: 27132318
    [No Abstract]   [Full Text] [Related]  

  • 13. Trends in long-acting reversible contraception use among U.S. women aged 15-44.
    Branum AM; Jones J
    NCHS Data Brief; 2015 Feb; (188):1-8. PubMed ID: 25714042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived and insurance-related barriers to the provision of contraceptive services in U.S. abortion care settings.
    Kavanaugh ML; Jones RK; Finer LB
    Womens Health Issues; 2011; 21(3 Suppl):S26-31. PubMed ID: 21530835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder.
    Matusiewicz AK; Melbostad HS; Heil SH
    Contraception; 2017 Nov; 96(5):365-369. PubMed ID: 28778423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers and Facilitators to Adolescents' Use of Long-Acting Reversible Contraceptives.
    Pritt NM; Norris AH; Berlan ED
    J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):18-22. PubMed ID: 27477904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of long-acting reversible contraceptives to reduce the rate of teen pregnancy.
    Rome E
    Cleve Clin J Med; 2015 Nov; 82(11 Suppl 1):S8-12. PubMed ID: 26555813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of publicly funded contraceptive services on unintended pregnancies and implications for Medicaid expenditures.
    Forrest JD; Samara R
    Fam Plann Perspect; 1996; 28(5):188-95. PubMed ID: 8886761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the Use of Long-Acting Reversible Contraceptive Methods Among U.S. Nulliparous Women: Results from the 2006-2010, 2011-2013, and 2013-2015 National Survey of Family Growth.
    Ihongbe TO; Masho SW
    J Womens Health (Larchmt); 2018 Mar; 27(3):245-252. PubMed ID: 29148890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing LARC utilization: any woman, any place, any time.
    Hathaway M; Torres L; Vollett-Krech J; Wohltjen H
    Clin Obstet Gynecol; 2014 Dec; 57(4):718-30. PubMed ID: 25314089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.